DemeRx Overview

  • Founded
  • 2010
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $290K
Latest Deal Amount
  • Investors
  • 1

DemeRx General Information


Provider of treatments for drug addiction. The company develops methods of treating patients for pain by administering noribogaine which is a non-addictive medication.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Managed Care
Other Industries
Other Healthcare
Primary Office
  • 305 South Andrews Aveue
  • Suite 515
  • Destin, FL 32541
  • United States
+1 (954) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DemeRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 08-May-2015 $290K 00.000 Completed Startup
1. Angel (individual) 27-Feb-2013 00.000 00.000 Completed Startup
To view DemeRx’s complete valuation and funding history, request access »

DemeRx Executive Team (4)

Name Title Board Seat Contact Info
Steven Gorlin Chief Executive Officer, Executive Chairman & Board Member
Holger Weis President
Charles Koob Executive Officer & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

DemeRx Board Members (8)

Name Representing Role Since
Brian Thebault DemeRx Board Member 000 0000
Bruce Hack DemeRx Board Member & Director 000 0000
Charles Koob DemeRx Executive Officer & Board Member 000 0000
Henry Mellon DemeRx Board Member 000 0000
Parker Petit DemeRx Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

DemeRx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Foley Ventures Venture Capital Minority 000 0000 000000 0
To view DemeRx’s complete investors history, request access »

DemeRx Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 (000 24-Jan-2020 00000 0000000 Drug Discovery 0000000 0000 00.0
To view DemeRx’s complete investments history, request access »